See more Today's research, tomorrow's health VHIR Academia Training Programmes Explore our educational offerings, including master's programmes, specialised courses, doctoral studies, and training placements designed to help you develop your potential in a world-class biomedical research environment. See more Today's research, tomorrow's health The new research building is a reality! The future of personalised medicine is closer with Vall d’Hebron’s new research building, which connects research and society to improve people’s lives See more Today's research, tomorrow's health Vall d'Hebron Research Institute More than 30 years working to identify and apply new solutions to society’s health problems, achieving leadership and excellence in clinical and translational biomedical research at the national and international levels. See more Today's research, tomorrow's health Leaders in clinical trials Clinical trials are our best strategy for making new therapeutic approaches and new treatment opportunities available to patients. The Vall d'Hebron Campus is an international benchmark in clinical trials. We closed the year 2025 with a figure of 1,555 active clinical trials. See more Today's research, tomorrow's health More than 60 research groups These research groups are structured in 6 research areas with the aim of solving some of the main challenges in the field of health. We promote impact research, aimed at improving the well-being of society. See more Today's research, tomorrow's health VHIR daily news All the latest news and information on major advances in research, institutional milestones, teaching and management. Find out what's happening at the Vall d'Hebron Research Institute! PreviousNext Get to know our collaborative research spaces (eCORE) Chronic & Prevalent Diseases Brain, Mind & Behaviour Cancer Diagnosis, Treatment & Techonology Infectious, Systemic and Acute Disorders NEWS Latest news Vall d’Hebron confirms the safety of live attenuated vaccines in multiple sclerosis The results show that live attenuated vaccines against measles, rubella, mumps and varicella do not increase the risk of relapses in people with multiple sclerosis. Vall d’Hebron promotes AI applied to healthcare through new initiatives AIDAY 2026 showcased the artificial intelligence initiatives, infrastructures and projects already being developed across the Campus. Vall d’Hebron identifies cases of a skin infection usually associated with animals All patients showed a favorable clinical course and responded well to antibiotic treatment, without complications. See more All the tools to research at your disposal The Core Facilities offer state-of-the-art solutions for all the needs that arise during the biomedical research process. Each unit is led by a person in charge of the day-to-day management of the activities, the evaluation of the quality of the service and the treatment to the clients. See more COLLABORATE Help us to make research move forward Our research activity seeks to discover less invasive therapies, to find treatments for incurable diseases and to anticipate diagnoses. Discover how you can collaborate. Help us to make research move forward. Because today’s research is tomorrow’s health. Donate We have the best professionals Enric Trilla Herrera Head of group Biomedical Research in Urology Read more Meritxell Genesca Ferrer Main researcher Infectious Diseases Read more Miguel Segura Ginard Head of group Childhood Cancer and Blood Disorders Read more Maria Espiau Guarner Senior researcher Infection and immunity in pediatric patients Read more See more
